Drug Profile
Research programme: atopic dermatitis treatments - DermTech
Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator DermTech International
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Atopic dermatitis
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Atopic-dermatitis in USA
- 16 May 2007 Preclinical trials in Atopic dermatitis in USA (unspecified route)